Table 5. Effect of LEV administration on reproductive hormones FSH, LH, and testosterone.
Experimental Groups | FSH (IU/L) |
LH (mg/dL) |
Testosterone (IU/L) |
---|---|---|---|
C | 12.63 ± 2.73 | 18.16 ± 3.73 | 4.87 ± 2.6 |
LEV-50 | 11.26 ± 1.76 | 16.14 ± 2.91 | 3.05 ± 1.85 |
LEV-150 | 10.44 ± 3.55 | 15.70 ± 3.05 | 3.44 ± 1.39 |
LEV-300 | 6.34 ± 1.77 (a,b,c) | 11.13 ± 2.90 (a,b,c) | 2.48 ± 1.26 (a) |
C: Control group; LEV-50: 50 mg/kg levetiracetam administered group; LEV-150: 150 mg/kg levetiracetam administered group; LEV-300: 300 mg/kg levetiracetam administered group; Results are Mean ± SD, n = 10.
(a) Different from control group (P < 0.05),
(b) Different from LEV-50 (P < 0.05),
(c) Different from LEV-150 (P < 0.05).